These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 9378990

  • 1. Fas (CD95, APO-1) antigen expression and function in murine mast cells.
    Hartmann K, Wagelie-Steffen AL, von Stebut E, Metcalfe DD.
    J Immunol; 1997 Oct 15; 159(8):4006-14. PubMed ID: 9378990
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I.
    J Immunol; 1999 Aug 01; 163(3):1315-20. PubMed ID: 10415029
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
    Urayama S, Kawakami A, Matsuoka N, Tsuboi M, Nakashima T, Kawabe Y, Koji T, Eguchi K.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):782-8. PubMed ID: 9367846
    [Abstract] [Full Text] [Related]

  • 9. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells.
    Marth T, Zeitz M, Ludviksson BR, Strober W, Kelsall BL.
    J Immunol; 1999 Jun 15; 162(12):7233-40. PubMed ID: 10358170
    [Abstract] [Full Text] [Related]

  • 10. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.
    J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 01; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 15. Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A.
    Rumsaeng V, Vliagoftis H, Oh CK, Metcalfe DD.
    J Immunol; 1997 Feb 01; 158(3):1353-60. PubMed ID: 9013979
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
    Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR.
    J Immunol; 1998 Aug 01; 161(3):1558-67. PubMed ID: 9686624
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
    Mekori YA, Metcalfe DD.
    J Immunol; 1994 Sep 01; 153(5):2194-203. PubMed ID: 7519644
    [Abstract] [Full Text] [Related]

  • 18. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A, Pestano GA, Cantor H.
    J Immunol; 1998 Jan 15; 160(2):559-65. PubMed ID: 9551888
    [Abstract] [Full Text] [Related]

  • 19. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
    Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH, Fontana A.
    Eur J Immunol; 1995 Aug 15; 25(8):2253-8. PubMed ID: 7545115
    [Abstract] [Full Text] [Related]

  • 20. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.
    J Immunol; 1999 Jun 15; 162(12):7350-7. PubMed ID: 10358186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.